ARG Forms Rare Disease Advisory Board

August 10, 2017

Applied Clinical Trials

Atlantic Research Group, Inc. (ARG)-a rare disease-focused contract research organization (CRO)-announced that it formed its rare disease strategic advisory board (SAB). The SAB will consist of outside scientific experts, patient advocates, and former executives from rare disease-focused biotechs. 

Read the full release here.


Related Content: